Nexalin Technology

Nexalin Technology Equity Ratio

The Equity Ratio of Nexalin Technology (NXL) as of Oct 17, 2026 is 80.86 %. In the previous year, Equity Ratio was 87.05 % — a change of -7.12% (lower).

Equity Ratio

80.86 %

YoY

-7.12%

Last updated:

Equity Ratio of Nexalin Technology is 2025 80.86 % . Equity Ratio of Nexalin Technology was 2024 87.05 % . It decreases by -7.12% lower compared to the previous year.

The Nexalin Technology Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2019
-1,048.27 USD
Jan 1, 2020
-1,342.49 USD
Jan 1, 2021
-223.16 USD
Jan 1, 2022
73.72 USD
Jan 1, 2023
88.29 USD
Jan 1, 2024
87.05 USD
Jan 1, 2025
80.86 USD
The Nexalin Technology Equity Ratio history
YEAREquity RatioYoY
80.86 %-7.12%
87.05 %-1.40%
88.29 %+19.77%
73.72 %-133.03%
-223.16 %-83.38%
-1,342.49 %+28.07%
-1,048.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nexalin Technology Stock analysis

What does Nexalin Technology do? Nexalin Technology Inc, headquartered in Laguna Niguel, California, designs and develops neurostimulation products within the US health care sector. Listed on September 16, 2022, the company employs six full-time staff members. Its flagship device, Generation 1, utilizes bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The non-invasive system applies a high-frequency, charge-balanced electrical current waveform via head electrodes, offering relief without adverse side effects. Additionally, Nexalin is designing clinical trials for Generation 2, targeting substance use disorders, particularly opiate abuse, as well as chronic pain, Alzheimer’s disease, and dementia. These devices operate using varying voltages and frequencies to address mental health issues effectively. Nexalin Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nexalin Technology stock

Equity Ratio of Nexalin Technology is 80.86 % in 2025.

Equity Ratio of Nexalin Technology changed from 87.05 % to 80.86 %, representing a -7.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Nexalin Technology since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Nexalin Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Nexalin Technology

All Key Metrics — Nexalin Technology